April 20, 2015 Foamix Pharmaceuticals Ltd. Announces Closing of its $69 Million Public Offering of Ordinary Shares View Article
April 15, 2015 Foamix Pharmaceuticals Ltd. Announces Upsizing and Pricing of its $60 Million Public Offering of Ordinary Shares View Article
April 1, 2015 Foamix Pharmaceuticals Ltd. Files Registration Statement for Proposed Follow-On Offering View Article
November 13, 2014 Foamix Announces Two New U.S. Patents Relating To Topical Tetracycline Compositions View Article
October 6, 2014 Foamix Pharmaceuticals Ltd. Announces Initiation of Phase II Trial with FDX104 in Chemotherapy Induced Rash View Article
September 23, 2014 Foamix Pharmaceuticals Ltd. Announces Closing of Initial Public Offering View Article
